Is central venous access in childhood osteomyelitis associated with increased morbidity?

Area of Science:

• Pediatric Infectious Diseases
• Vascular Access Devices
• Surgical Outcomes

Background:

• Children with osteomyelitis require prolonged intravenous antibiotic therapy.
• Central venous lines (CVLs) are essential for administering long-term antibiotics in pediatric patients.
• Hickmann-type CVLs are a common choice for secure venous access.

Purpose of the Study:

• To evaluate the safety and efficacy of surgically inserted Hickmann-type CVLs in children with osteomyelitis.
• To assess the morbidity associated with CVLs in this specific pediatric patient population.
• To determine the suitability of CVLs for prolonged antibiotic administration in pediatric osteomyelitis.

Main Methods:

• A retrospective study of 17 pediatric patients with osteomyelitis.
• Analysis of 20 surgically inserted Hickmann-type CVLs used between 1992 and 1996.
• Evaluation of line duration, complications (line sepsis, exit-site infection), and overall outcomes.

Main Results:

• The study included patients aged 1 month to 14 years.
• CVL usage ranged from 6 to 180 days.
• Only two complications were reported: one line sepsis and one exit-site infection, leading to CVL removal.

Conclusions:

• Surgically inserted Hickmann-type CVLs are a safe and effective method for prolonged antibiotic administration in pediatric osteomyelitis.
• The use of CVLs in children with osteomyelitis did not lead to increased morbidity related to line sepsis.
• Hickmann-type CVLs successfully facilitated the necessary long-term antibiotic treatment for pediatric bone infections.